Reflection on existence of neural and non-neural pathway for nose- to- brain using a novel formulation of an anticholinesterase piperidine derivative

Current Nanoscience

Volumn 6, Issue 3, 2010, Pages 320-323

  Ali, Javed ^a   Ali, Mushir ^a   Baboota, Sanjula ^a   Ali, Rashid ^b   Mittal, Gaurav ^b   Bhatnagar, Aseem ^b   Bhavna, ^a  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Nasal drug delivery; Neural; Non neural; Nose to brain; Olfactory; Radiolabeled; Trigeminal

Indexed keywords

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; DRUG ADMINISTRATION; DRUG CONCENTRATION; INTRANASAL; IONIC CROSSLINKING; NANO PARTICULATES; NASAL DELIVERY; NASAL DRUG DELIVERY; NEURAL PATHWAY; NEURODEGENERATIVE DISORDERS; NONINVASIVE METHODS; RAT MODEL; SIDE EFFECT; SPINAL CORDS; THERAPEUTIC AGENTS;

CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; DRUG PRODUCTS; FLAVORS;

RATS;

CHITOSAN; NANOPARTICLE; PIPERIDINE DERIVATIVE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; NERVE TRACT; NONHUMAN; NOSE CAVITY; OLFACTORY NERVE; PRIORITY JOURNAL; RAT; TRIGEMINAL NERVE;

RATTUS;

EID: 77953991712     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341310791171135     Document Type: Article

References (19)

1. Mathison, S.; Nagilla R.; Kompella, U.B. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J. Drug Target, 1998, 5, 415-441.
2. Illum, L. Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci., 2000, 11, 1-/18.
3. Turker, S.; Onur, E.; Ozer, Y. Nasal route and drug delivery systems. Pharm. World Sci., 2004, 26(3), 137-142.
4. Faber, W. N. The nasal mucosa and the sub- arachnoid space. Am. J. Anat., 1937, 67, 121-148.
5. Chou, K.-J.; Donovan M. D. The distribution of local anaesthetics into the CSF following intranasal administration. Int. J. Pharm., 1998, 168, 137-145.
6. Frey, W.H.; Liu, J.; Chen, X.; Thorne, R.G.; Fawcett, J.R.; Ala, T.A,; Rahman, Y.-E. Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv., 1997, 4, 87-92.
7. Henriksson, J.; Tjalve, H. Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats. Environ. Res., 1998, 77, 130-140.
8. Brittebo, E. B.; Eriksson, C. Taurine in the olfactory system: effects of the olfactory toxicant dichlobenil. Neurotoxicology, 1995, 16, 271-280.
9. Wang, Y.; Aun, R.; Tse, F.L.S. Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat. Biopharm. Drug Dispos., 1998, 571-575.
10. Eriksson, C.; Bergman, U.; Franzen, A.; Sjoblom, M.; Brittebo, E. B. Transfer of some carboxylic acids in the olfactory system following intranasal ad-ministration. J. Drug Target., 1999, 7, 131-142.
11. Yajima, T.; Juni, K.; Saneyoshi, M.; Hasegawa, T.; and Kawaguchi, T. Direct transport of 2', 3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats. Biol. Pharm. Bull., 1998, 21, 272-277.
12. Charlton, S.T.; Davis, S.S.; Illum, L. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies. J. Control Release, 2007, 118(2), 225-234.
13. Frey, W.H. 2nd: (WO/1991/007947) Neurologic Agents for Nasal Administration to the Brain (priority date 5.12.89). Geneva, Switzerland: World In-tellectual Property Organization, 1991.
14. Chen, X.-Q.; Fawcett, J.R.; Rahman, Y.-E.; Ala, T.A.; Frey, W.H. 2nd. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimers Dis., 1998, 1, 35-44.
15. Henry, R.J.; Ruano, N.; Casto, D.; Wolf, R.H. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration. Pediatr. Dent., 1998, 20(5), 321-326.
16. Sakane, T.; Akizuki, M.; Yoshida, M.; Yamashita, S.; Nadai, T.; Hashida, M.; Sezaki, H. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J. Pharm. Pharmacol., 1991, 43(6), 449-451.
17. Bhavna.; Sharma, V.; Ali, M.; Baboota, S.; Ali. J. Preparation and Characterization of chitosan nanoparticles for nose-brain -delivery of a cholinesterase inhibitor. Ind. J. Pharm. Sci., 2007, 69 (5), 712-713.
18. Bhavna.; Lakra, R.; Singh, T.; Swaroop, K.; Ali, M.; Bhatnagar, A.; Ali. J. Demonstration of olfactory nerve: Brain Shunt using a lipophilic drug and analyzing by radiometry and Scintigraphy. Ind. J. Nucl. Med., 2008, 23(2), 60-61.
19. Hongbing, Wu.; Kaili, Hu,.; Xinguo, J. From nose to brain: understanding transport capacity and transport rate of drugs. Exp. Opin. Drug Deliv., 2008, 5(10), 1159-1168.